Does Treatment of Androgen Excess Using Spironolactone Improve Ovulatory Rates in Girls With Androgen Excess?

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 18, 2019

Primary Completion Date

September 1, 2024

Study Completion Date

September 1, 2024

Conditions
Polycystic Ovary SyndromePuberty DisordersOvulation Disorder
Interventions
DRUG

Spironolactone

Spironolactone is an androgen-receptor commonly used (off-label) for hyperandrogenism in girls and women. It is used in this study to determine if androgen blockade can improve ovulation rates in girls with androgen excess, who often have low rates of ovulation in the years following menarche. The spironolactone dose will be as follows: If ≤ 60 kg, 50 mg twice daily; if \> 60 kg, 100 mg twice daily.

Trial Locations (1)

22908

RECRUITING

University of Virginia Center for Research in Reproduction, Charlottesville

All Listed Sponsors
collaborator

The Waterloo Foundation

OTHER

lead

University of Virginia

OTHER